Month: July 2026

IgA Realted Diseases

The renal group

IgA nephropathy (primary)
The commonest primary glomerulonephritis worldwide, with a marked predilection for East Asian and, to a lesser extent, European populations, and a peak in the second and third decades. The clinical signature is synpharyngitic visible haematuria — gross haematuria within a day or two of a mucosal (usually upper respiratory) infection — which contrasts usefully with the one-to-two-week latency of post-streptococcal GN. The rest present with asymptomatic microscopic haematuria and variable proteinuria picked up on screening. Pathogenesis is the four-hit model: circulating galactose-deficient IgA1 (hit one), glycan-specific autoantibodies against it (hit two, often IgG), immune-complex formation (hit three), and mesangial deposition with alternative- and lectin-pathway complement activation (hit four). Light microscopy shows mesangial hypercellularity and matrix expansion, with variable endocapillary proliferation, crescents and segmental sclerosis; the Oxford MEST-C score formalises the prognostically relevant lesions. IF gives dominant/codominant mesangial IgA with C3, frequently IgG/IgM, and — the point that keeps recurring — no C1q. EM confirms paramesangial dense deposits. Course is heterogeneous, with a substantial minority reaching ESRD over two decades.

IgA vasculitis nephritis (Henoch–Schönlein)
Best understood as the systemic expression of the same galactose-deficient-IgA1 biology, so the renal lesion is histologically and immunopathologically indistinguishable from primary IgAN — the biopsy alone cannot separate them. What separates them is the clinical tetrad: palpable purpura over the buttocks and lower limbs, arthralgia/arthritis, abdominal pain (with the risk of intussusception and GI haemorrhage), and nephritis. It is the commonest vasculitis of childhood, tends to be self-limiting in children, and behaves worse renally in adults. Crescents dominate the prognosis, and the paediatric lesion is graded by the ISKDC crescent-based scheme rather than MEST-C. Skin DIF shows perivascular IgA, tying it to the cutaneous vasculitis below.

IgA-dominant infection-related GN
The classic trap on this panel: IgA dominance or codominance in a GN that is emphatically not IgAN. It is typically staphylococcal (MRSA or MSSA), disproportionately in older and diabetic patients, and — unlike post-streptococcal disease — the infection is often ongoing rather than resolved (deep-seated soft-tissue, skin, endocarditis or visceral). Histology is an acute diffuse endocapillary and exudative proliferative GN with neutrophils, sometimes crescents, and subepithelial “humps” on EM. IF shows IgA with characteristically strong C3. The disambiguators from IgAN are therefore threefold: the clinical setting (active infection, diabetic/elderly), the exudative proliferative morphology with humps, and the disproportionate C3. Prognosis is guarded, especially in diabetics.

Lupus nephritis (as mimic)
Included only because its “full-house” IF (IgG, IgA, IgM, C3 and C1q) contains IgA, so isolated attention to the IgA channel is misleading. C1q positivity is the swing marker that pulls the case towards lupus and away from IgAN. Corroborating features — tubuloreticular inclusions on EM, wire-loop deposits, extraglomerular deposits along the TBM and vessels — and the ISN/RPS class then take over. IgA here is a passenger, never dominant in the IgAN sense.

Secondary (“hepatic”) mesangial IgA
Reduced hepatic clearance of IgA and IgA-containing immune complexes in chronic liver disease — most consistently alcohol-related cirrhosis with portal hypertension — produces mesangial IgA deposition that is usually clinically silent and lacks the proliferative lesion of primary IgAN. The same incidental deposition is described, less consistently, in coeliac disease, IBD, HIV, dermatitis herpetiformis and the seronegative spondyloarthropathies. The practical error to avoid is reading incidental mesangial IgA as primary IgAN without the clinicopathological context.

The cutaneous group

Dermatitis herpetiformis
The cutaneous face of coeliac disease: intensely pruritic grouped papulovesicles over extensor surfaces — elbows, knees, buttocks, scalp — usually excoriated by the time they present. Histology is a subepidermal blister with neutrophilic microabscesses at the tips of the dermal papillae. DIF on perilesional or clinically normal skin shows granular IgA at the papillary tips (with variable BMZ granularity). The autoantigen is epidermal transglutaminase (TG3), the cousin of the tissue transglutaminase (TG2) targeted in gut coeliac disease, and the HLA association is DQ2/DQ8. It responds to a gluten-free diet and to dapsone. The clinically useful cross-link for your GI work: a confirmed DH diagnosis is effectively a coeliac diagnosis, and these patients carry the associated enteropathy and lymphoma risk even when gut symptoms are absent.

Linear IgA bullous dermatosis
A subepidermal blistering disease defined by homogeneous linear IgA along the basement membrane zone — the pattern, not the immunoglobulin class alone, is what distinguishes it from DH. It has an adult idiopathic form and a childhood form (chronic bullous disease of childhood) with the characteristic annular “cluster of jewels”/string-of-pearls arrangement of peripheral blisters. The drug-induced variant is classically vancomycin-associated (also captopril, NSAIDs and others). The target antigens are cleavage products of BP180/collagen XVII (LAD-1, LABD97). Routine histology — a subepidermal blister with neutrophils — overlaps with both DH and bullous pemphigoid, so DIF is the arbiter: linear rather than granular, IgA rather than IgG.

IgA pemphigus
Intraepidermal acantholysis with intercellular (“chicken-wire”) IgA on DIF — the same cell-surface pattern as classical pemphigus but with IgA replacing IgG, and generally a more pustular, less erosive clinical picture (flaccid pustules, sometimes sunflower-like annular lesions with central crust). Two subtypes: the subcorneal pustular dermatosis (SPD) type, with subcorneal pustules and desmocollin 1 as the target antigen, and the intraepidermal neutrophilic (IEN) type, with pustules deeper in the epidermis and a less consistently defined antigen. The contrast to hold in mind is that pemphigus vulgaris and foliaceus are IgG-mediated intercellular disease; IgA pemphigus is their IgA counterpart, generally milder and steroid/dapsone-responsive.

Cutaneous IgA vasculitis
A leukocytoclastic vasculitis of superficial dermal small vessels with perivascular IgA on DIF — the skin lesion (palpable purpura) that, when accompanied by the systemic tetrad, marks IgA vasculitis, and which links directly back to the renal lesion above. The presence of IgA in the vessel walls is what elevates a non-specific leukocytoclastic vasculitis into this specific, systemically significant category.

The immunodeficiency

Selective IgA deficiency
The commonest primary immunodeficiency in populations of European descent (roughly 1 in 300–700), defined by very low or absent serum IgA with preserved IgG and IgM. Most are asymptomatic; a minority have recurrent sinopulmonary and GI infection, atopy, or autoimmune disease. In tissue it shows as reduced or absent IgA plasma cells in the lamina propria, and it associates with nodular lymphoid hyperplasia and giardiasis. Two practical consequences deserve flagging on any sheet: it invalidates IgA-based coeliac serology (the IgA-tTG will be falsely negative, so total IgA must be checked and IgG-based tests used instead), and it carries a risk of anaphylactic transfusion reactions to IgA-containing blood products in patients who have formed anti-IgA antibodies.

CDX2 Immunohistochemistry

CDX2 Immunohistochemistry

CDX2 is a homeobox transcription factor involved in intestinal epithelial development and differentiation. In diagnostic IHC, it is used as a sensitive and relatively specific marker of intestinal differentiation, most commonly applied to identify adenocarcinomas of gastrointestinal origin — particularly colorectal adenocarcinoma. Staining is nuclear.

Utility and limitations

CDX2 positivity is seen in the great majority of colorectal adenocarcinomas, making it a workhorse marker when confirming intestinal-type differentiation in a metastatic adenocarcinoma of unknown primary. However, it is not colorectal-specific: CDX2 is also expressed in a range of other tumours with intestinal or intestinal-type differentiation, including gastric adenocarcinoma (particularly intestinal-type), a subset of pancreaticobiliary adenocarcinomas, mucinous ovarian tumours, and some urothelial carcinomas with glandular/intestinal metaplasia.

Loss of CDX2 expression has also been reported as a marker of aggressive behaviour and worse prognosis in a subset of colorectal cancers, and can occur in poorly differentiated or dedifferentiated tumours — so a negative result doesn’t exclude colorectal origin, especially in high-grade lesions.

Panel context

Because of these overlaps, CDX2 is best used as part of a panel rather than as a standalone site-of-origin marker:

  • CK7/CK20: classic colorectal profile is CK20+/CK7−, though this pattern has well-known exceptions.
  • SATB2: increasingly regarded as more specific for colorectal origin than CDX2, since SATB2 is less frequently positive in upper GI and pancreaticobiliary tumours.
  • Villin: broadly supports intestinal/brush-border differentiation but shows similarly broad expression across GI sites.

Combining CDX2 with SATB2, CK7, CK20, and villin gives a more reliable picture of the site of origin than any single marker, particularly when trying to distinguish colorectal from upper GI or pancreaticobiliary adenocarcinoma in a metastatic workup.

BSEP (Bile Salt Export Pump) Immunohistochemistry

Bile Salt Export Pump (BSEP) is an ATP-binding cassette transporter protein (encoded by ABCB11) that functions as the major canalicular bile salt transporter in hepatocytes. In diagnostic pathology, BSEP IHC is used primarily as a canalicular marker for hepatocellular carcinoma and in the diagnosis of bile salt export pump deficiency in progressive familial intrahepatic cholestasis type 2 (PFIC2).

Hepatocellular carcinoma

BSEP shows a canalicular (“chicken-wire”) staining pattern in tumour cells, reflecting its normal physiological role as a bile salt transporter. This pattern confirms hepatocellular differentiation and helps distinguish HCC from metastatic adenocarcinoma or cholangiocarcinoma, neither of which forms canaliculi and therefore won’t show this staining pattern.

BSEP functions conceptually alongside other canalicular markers such as polyclonal CEA and CD10, and is generally considered more sensitive and specific than pCEA in some series.

Loss or reduction of BSEP staining has also been reported in poorly differentiated HCC and in some cholestatic hepatocellular lesions, so absent staining isn’t specific on its own — pattern interpretation in context matters.

Progressive Familial Intrahepatic Cholestasis Type 2

PFIC2 results from biallelic ABCB11 mutations. Liver biopsy IHC typically shows absent or markedly reduced canalicular BSEP staining, supporting the diagnosis alongside clinical/biochemical features (low-GGT cholestasis, elevated bile acids) and molecular confirmation.

A useful nuance: some ABCB11 missense mutations produce a mistrafficked but partially functional protein, which can show weak/patchy canalicular staining or an intracellular rather than purely canalicular pattern — so BSEP IHC is supportive but not strictly binary, and genetic testing remains the gold standard.

PFIC2 patients with BSEP deficiency also carry an increased risk of hepatocellular carcinoma and cholangiocarcinoma at a young age, which is relevant when assessing paediatric explant or resection specimens.